Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6178653 | Fertility and Sterility | 2015 | 9 Pages |
Abstract
Antimüllerian hormone was a stronger predictor of ovarian response to gonadotropin therapy than AFC at the study center level in both randomized trials utilizing GnRH agonist and GnRH antagonist protocols. Antral follicle count provided no added predictive value beyond AMH.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Scott M. M.R.C.O.G., Ph.D., Bjarke M. Ph.D., Joan-Carles M.D., Ph.D.,